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Regulation of the cerebral circulation relies on the complex interplay between cardiovascular, respiratory, and neural
physiology. In health, these physiologic systems act to maintain an adequate cerebral blood flow (CBF) through
modulation of hydrodynamic parameters; the resistance of cerebral vessels, and the arterial, intracranial, and venous
pressures. In critical illness, however, one or more of these parameters can be compromised, raising the possibility
of disturbed CBF regulation and its pathophysiologic sequelae. Rigorous assessment of the cerebral circulation
requires not only measuring CBF and its hydrodynamic determinants but also assessing the stability of CBF in
response to changes in arterial pressure (cerebral autoregulation), the reactivity of CBF to a vasodilator (carbon
dioxide reactivity, for example), and the dynamic regulation of arterial pressure (baroreceptor sensitivity). Ideally,
cerebral circulation monitors in critical care should be continuous, physically robust, allow for both regional and
global CBF assessment, and be conducive to application at the bedside. Regulation of the cerebral circulation is
impaired not only in primary neurologic conditions that affect the vasculature such as subarachnoid haemorrhage
and stroke, but also in conditions that affect the regulation of intracranial pressure (such as traumatic brain injury
and hydrocephalus) or arterial blood pressure (sepsis or cardiac dysfunction). Importantly, this impairment is often
associated with poor patient outcome. At present, assessment of the cerebral circulation is primarily used as a
research tool to elucidate pathophysiology or prognosis. However, when combined with other physiologic signals
and online analytical techniques, cerebral circulation monitoring has the appealing potential to not only prognosticate
patients, but also direct critical care management.Background
To function, the brain requires adequate delivery of
nutrients and oxygen. A circulatory system is therefore
required to maintain an optimal cerebral blood flow
(CBF) for the brain’s diverse needs. Whilst oxygen and
nutrient delivery is in part dependent on the pump sup-
plying it—the heart—the circulatory system has also
evolved mechanisms to ensure the precise control of
CBF. The cerebral vessels have the remarkable ability to
rapidly adapt and react to the brain’s chemical environ-
ment, to neuronal signals, and to the pressure within the
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cerebrovascular physiology and cerebral circulation
monitoring techniques before outlining the state of
current knowledge of the cerebral circulation in selected
critical illnesses and highlighting promising areas for fu-
ture research.Review
Regulation of cerebral blood flow
A haemodynamic model for the cerebral circulation has
been described that allows for interrogation of the regu-
lation of CBF [1, 2]. In such a model, CBF is dependent
on the pressure supplied in the cerebral arteries (arterial
blood pressure (ABP)), the back pressure in the cerebral
venous system (usually close to intracranial pressure
(ICP)), and the resistance related to the diameter of thele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Fig. 1). This relationship can be simplified as:
CBF ¼ ABP− ICP
CVR
Thus, cardiovascular, ICP, and cerebrovascular compo-
nents are all important regulators of the cerebral circula-
tion. Applying this model can provide crucial insights
into the physiologic factors that regulate cerebral perfu-
sion in health and elucidate why CBF regulation is often
impaired in pathologic states.
The cardiovascular component
As early as 1890, Sherrington and Roy underlined
the importance of the ABP in the regulation of CBF:
‘One of the most evident of the facts observed by us
is that the blood-supply of the brain varies directly
with the blood pressure in the systemic arteries’ [3].
The pressure that supplies the cerebral vessels is
dependent on factors mostly outside the brain itself:
the heart provides the cardiac output while the per-
ipheral vessels provide the resistance, both of whichFig. 1 Regulation of the cerebral circulation. CBF at the level of the mi
ABP and ICP) and inversely proportional to CVR. ICP exerts its effect on
vasculature where the bridging veins enter the sagittal sinus ensures th
always above ICP. CBF is modulated by the cardiovascular system in te
vasopressors forms an integral part of many CBF protective strategies (
is regulated at the level of the arterioles (purple) by variations in vascu
ischaemic stroke or vasospasm, CVR is dramatically increased, usually at
through its coupling with cerebral venous pressure. ICP increases can b
venous), increased CSF volume or increase in parenchyma (oedema),
modulate CBF do so via one (or more) of these pathways. There is ty
determinants, and influences of CBF. For example, a drop in ABP wou
due to the baroreflex (HR increase in response to drop in ABP) and c
drop in ABP). ABP arterial blood pressure, CBF cerebral blood flow, CB
cerebrovascular resistance, EVD external ventricular drainage, HR heart rate, IC
volume, TPR total peripheral resistancecontribute to the ABP supplying the brain. In this
sense, the balance between the brain CVR and the
total peripheral resistance determines the proportion
of the cardiac output that reaches the brain. Thus,
any pathological or physiological event that affects
the heart or the vasculature as a whole has the po-
tential to alter the cerebral circulation. Cardiogenic
shock and arrhythmia may therefore impair CBF [4],
as do conditions that affect the systemic vasculature
such as sepsis [5].
Just as pathologies affecting ABP can affect CBF, ther-
apies to augment CBF often do so by modulating ABP.
Vasopressors act to buffer ABP by constricting periph-
eral vessels, while inotropes act to modulate cardiac out-
put (Fig. 1). An important consideration of such an
approach is that the relationship between changes in
ABP and CBF is typically non-linear due to active
changes in vascular tone occurring at the level of the
cerebral arterioles—a process known as cerebral auto-
regulation (see later). Furthermore, modulating ABP as a
therapeutic measure will not only increase blood flow to
the brain, but will also increase blood flow to any vascu-
lar beds with a low vascular resistance.crovasculature is directly proportional to CPP (difference between
CBF through changes in CPP; compression of the venous
at the bridging vein and post-capillary intravascular pressure is
rms of the regulation of SV, HR, and TPR (red). Control of TPR with
even when TPR is not the primary cause of CBF disturbance). CVR
lar tone in response to metabolic, neural, or myogenic inputs. In
the level of large intracranial arteries. ICP (blue) modulates CBF
e caused by increases in cerebral blood volume (arterial or
or abnormal material volume (mass lesion). All therapies that
pically significant interdependence between the therapies,
ld be expected to result in a drop in CBF but this is short lived
erebral autoregulation (decrease in vascular tone in response to
V cerebral blood volume, CSF V cerebrospinal fluid volume, CVR
P intracranial pressure, IIH idiopathic intracranial hypertension, SV stroke
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At the distal end of the microvasculature is the cerebral
venous pressure, which provides a back pressure that
may impede CBF. The venous pressure in turn will be
related to both the venous pressure in the larger cerebral
veins and the ICP. If the ICP is above the pressure in the
lateral lacunae that feed into the large venous sinuses
(which are exposed to the cerebrospinal fluid (CSF)
space; Fig. 1), then these vessels will be compressed lead-
ing to a post-capillary venous pressure just above the
ICP [6, 7].
Any increase in ICP has the potential to decrease
the longitudinal pressure gradient across the vascular
bed—the cerebral perfusion pressure (CPP = ABP –
ICP)—and, provided there are no compensatory
changes in CVR, to decrease CBF. Thus, CBF is im-
paired by conditions that impede cerebral venous out-
flow (such as idiopathic intracranial hypertension or
neck position) and by conditions that increase ICP
(such as the oedema associated with traumatic brain
injury (TBI) or subarachnoid haemorrhage (SAH)).
Because the skull is rigid, any increase in volume of a
brain compartment can cause an increase in ICP.
Increases in volume of the intravascular compartment,
the CSF compartment, or the brain parenchymal com-
partment can all increase ICP and therefore decrease
CBF. These compartmental volume changes could be
caused by vascular dilation, hydrocephalus, or cerebral
oedema. Therapies that alter CBF via ICP changes in-
clude mild hyperventilation to decrease vascular volume,
CSF diversion through external ventricular drainage to
decrease CSF volume, osmotherapy to reduce the brain
tissue volume, or decompressive craniectomy to increase
the space available for the brain parenchyma (Fig. 1).
The cerebrovascular component
At the level of the brain vessels themselves, CBF can be
controlled by active changes in the diameter of the
‘regulating’ vessels, thus influencing the CVR.
The major site of active regulation of the cerebral cir-
culation is thought to be at the level of the arterioles
with their thick smooth muscle layer and ability for pro-
found dilation and constriction [1, 2]. However, larger
conduit arteries, capillaries, and venous structures may
also be important in certain situations [8–11]. For ex-
ample, during neuronal activation, relaxation of pericytes
surrounding capillaries has been considered to account
for a large proportion of the flow increase [9]. Cerebral
venules and veins are characterised by a low density of
smooth muscle cells and therefore have the ability to in-
crease volume with any increase in pressure; that is, they
exhibit a high compliance [11]. While probably not im-
portant in the active regulation of CBF, the compliant
nature of venous structures may play a passive role inthe regulation of CBF; for example, arteriolar dilation
leads to an increase in the volume of post-capillary ve-
nules that increases cerebral blood volume [12] and by
extension could increase ICP, decrease CPP, and there-
fore limit the increase in CBF.
In health, such changes in CVR or CBF are most
obvious during brain activation; an increase in neur-
onal activity elicits a prompt and significant increase
in CBF [13] mediated through vessel dilation. Alterna-
tively, during an ischaemic stroke, a portion of the
cerebral vasculature is mechanically occluded by a
thrombus causing a localised increase in CVR and a
decrease in CBF. During the vasospasm associated
with SAH, large cerebral arteries constrict, again
resulting in an increased local CVR and decreased
CBF [14].
Changes in vascular tone of the cerebral vessels are
caused by putative constricting and dilating substances.
Such vasoactive substances may be supplied to the ves-
sels via the bloodstream (e.g. arterial pressure of carbon
dioxide (PaCO2)), produced locally (see ‘Neurovascular
coupling’), or reach the smooth muscle fibres through
direct autonomic innervation. Not surprisingly, this het-
erogeneity in the possible sites of vasoactive substance
production can lead to difficulty in disentangling physio-
logical mechanisms. For example, modulation of ventila-
tion is commonly used to assess the function of the
cerebral vasculature (see ‘Carbon dioxide reactivity’);
however, such a stimulus can in principle alter cerebro-
vascular tone through three separate mechanisms:
changes in PaCO2 reaching the brain [15], changes in
autonomic activity [16], or direct changes in neuronal
activity [17].
Synaptic transmission with its resulting glutamate
release is the important stimulus for neurovascular
coupling through the production of vasoactive metabolites
such as arachidonic acid derivatives (20-hydroxy-eicosate-
traenoic acid, prostaglandins, epoxyeicosatrienoic acids),
lactate, adenosine and nitric oxide [8]. The site of
production of these metabolites includes the neuron,
the astrocyte, and the smooth muscle cells them-
selves. Both neurons and astrocytes are ideally placed
to mediate neurovascular coupling as they lie in close
proximity to both the neuronal synapse where the
signal is initiated and the smooth muscle cells of the
regulating microvasculature; however, the relative im-
portance of neurons versus astrocytes for neurovascu-
lar coupling is uncertain [8]. Regardless of the site of
production, the site of action is the smooth muscle fibres
surrounding the arterioles, or capillaries where the vaso-
active substances produce changes in intracellular calcium
concentration, which in turn alters the degree of smooth
muscle contraction, and vessel constriction. For further
review on neurovascular coupling, see [8, 18–22].
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vascular tone of cerebral vessels. Despite animal studies
demonstrating a rich innervation of both the dilating
parasympathetic and constricting sympathetic fibres, the
autonomic control of CBF in humans remains contro-
versial [23, 24] with the divergence in opinions probably
owing to between-species variation in autonomic innerv-
ation, variations in brain metabolism between experi-
ments, and heterogeneous autonomic nerve distribution
in the different studies [25]. Nevertheless, stimulation of
the trigeminal ganglion in humans decreases the esti-
mated CBF [26] while blockade of the stellate ganglion
increases the estimated CBF [27], highlighting a role for
the sympathetic nervous system in the regulation of the
cerebral circulation in humans.
In addition to the cerebrovascular, mean arterial pres-
sure, and ICP components, cardiac output has recently
been suggested to be an independent regulator of CBF
[28]. Evidence for such a view comes from studies dem-
onstrating a change in CBF after interventions that
change cardiac output but have no effect on mean arter-
ial pressure [28, 29]. An additional measure of CBF
regulation could thus be assessing CBF as a fraction of
the cardiac output. Although continuous and accurate
measures of cardiac output are less practical than ABP,
such an approach may provide additional insight into re-
gional blood flow regulation in health and disease.
According to the conventional model (Fig. 1), for an
increase in cardiac output to produce an increase in
CBF without a change in ABP, both total peripheral
resistance and CVR must decrease. As such, the auto-
nomic nervous system has been speculated as the mech-
anism by which changes in cardiac output may alter
CBF without changes in ABP [28]; however, a metro-
logical issue should also be considered. The ABP mea-
sured in the examined studies (and the majority of
vascular regulation investigations) is not the ABP in the
large cerebral arteries, but the pressure in a small per-
ipheral vessel or that estimated non-invasively at the fin-
ger or arm. Thus, in situations where an increase in
cardiac output causes an increased CBF and seemingly
unchanged ABP (estimated at the arm), it is possible that
cerebral arterial pressure actually increases. This issue
needs to be verified, probably in an animal model.
Finally, the simple schema provided in Fig. 1 must be
interpreted with the knowledge of the interdependence
of variables. The cerebral circulation appears to have
several cerebroprotective mechanisms; for example, if
ABP decreases, aortic and carotid baroreceptors will
alter autonomic outflow to increase HR and therefore
buffer ABP and CBF [30]. Similarly, as proposed by
Lassen and elaborated upon by others, in response to
a decrease in ABP, vessels will dilate in attempt to
buffer CBF [31, 32]. These important cerebroprotectiveprocesses are known as baroreceptor sensitivity and cere-
bral autoregulation.
How to assess the regulation of cerebral blood flow
Given the importance of CBF regulation in many patho-
logical states, the availability of accurate and practical
assessment methodologies is crucial. Often the choice of
an appropriate measurement technique depends upon
the clinical need; a balance between availability, accur-
acy, and practicality must be reached.
Non-invasive monitoring techniques include trans-
cranial Doppler (TCD) and near-infrared spectroscopy
(NIRS) (for a recent review, see [33, 34]). Such mo-
dalities have several important advantages making
them suitable for interrogating CBF regulation in the
clinical setting (Table 1). First, both TCD and NIRS
systems are portable and non-invasive, making assess-
ment feasible in the emergency room, the critical care
unit, or the operating theatre. Moreover, they capture
high-frequency and continuous data that can be com-
bined with other modalities (such as ABP or end-tidal
carbon dioxide (CO2)) to give information on cerebral
autoregulation and CO2 reactivity (see ‘Carbon dioxide
reactivity’).
Invasive cerebral perfusion methods include brain
tissue oxygen monitoring, laser Doppler flowmetry,
and thermal diffusion (for review of methodology
principles, see [35–37]). Whilst obviously only suit-
able for critically ill patients because of their inva-
sive nature, these methods have the advantage of
being relatively robust for long-term monitoring of
the cerebral circulation. Brain imaging techniques
(computerised tomography (CT), positron emission
tomography, and magnetic resonance imaging) have
the advantage of offering a high spatial resolution of
CBF data and the ability to asses absolute CBF, but
are at present not suitable for bedside monitoring
because of size, temporal resolution, and radiation
exposure [38].
Extended assessment of cerebral blood flow regulation
Because of the interdependence of the factors con-
trolling CBF, it is important to measure these factors
(ABP and ICP) in addition to CBF. Further, one can
assess the regulation of the system by assessing the
efficiency of the cardiac maintenance of ABP through
the baroreflex sensitivity and assessing the brain vas-
cular reactivity using the CBF reactivity to a vasodila-
tor stimulus (CO2 reactivity), to a perfusion pressure
challenge (cerebral autoregulation), or to a burst of
neuronal activity (neurovascular coupling). Such ex-
tended assessment allows for a comprehensive under-
standing of the vulnerability of a patient’s cerebral
circulation.
Table 1 Clinical assessment methodologies for the cerebral circulation
Method Principle Global or local
CBF assessment
Robustness Invasive Bedside Continuous Advantage Disadvantage
TCD [33] Doppler principle Global (vascular
territory)
Fair No Yes Yes High-frequency
signal
Signal easily lost.
Flow velocity
assessment only
NIRS [34] Absorbance of
oxygenated and
deoxygenated
haemoglobin
Local Good No Yes Yes Easy application Uncertain intracranial
contribution to signal
PBTO2 [37] Clark electrode Local Excellent Yes Yes Yes Robust Local
LDF [36] Doppler principle Local Excellent Yes Yes Yes Assessment of
microcirculation
Unknown biological
zero
Thermal
diffusion [35]
Thermal diffusion Local Excellent Yes Yes Yes Absolute CBF Frequent calibrations
Duplex neck
US [106]
Doppler principle Global Poor No Potentially No Absolute and
global CBF
Semi-continuous
CT [107] Time-dependent
attenuation of
iodine IV contrast
bolus (perfusion CT)
or Xe gas
Global and
local
Excellent No Potentially No Global and
regional CBF
Bulky and
intermittent
PET [108] Radioactive tracers
emit positrons
dependent on
perfusion
Global and
local
Excellent Minimal (venous
access)
No No Regional CBF
and metabolism
Radiation, requires a
cyclotron
MRI [109] Perfusion-dependent
decrease in T2 signal
with gadolinium
Global and
local
Excellent Minimal (IV access)
or no for arterial
spin labelling
technique
No No Absolute,
regional and
global CBF
Time-consuming,
expensive, difficult
to assess critically
ill patients
CBF cerebral blood flow, CT computerised tomography, IV intravenous, LDF laser Doppler flowmetry, MRI magnetic resonance imaging, NIRS near-infrared
spectroscopy, PBTO2 pressure of brain tissue oxygen, PET positron emission tomography, TCD transcranial Doppler, US ultrasound
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The cerebral vasculature is exquisitely sensitive to
changes in the PaCO2: with a decrease in pressure of
carbon dioxide (PCO2), cerebral resistance vessels
constrict; and with an increase in PaCO2, cerebral
vessels dilate [15]. These alterations in vascular tone
are probably mediated by changes in extracellular
hydrogen ion concentration resulting from diffusion
of PCO2 from inside the vessels. Several lines of evi-
dence indicate that cerebrovascular reactivity may be
a non-invasive and practical marker of cerebrovascu-
lar health (see ‘Clinical applications of bedside assess-
ment of CBF regulation’).
The CO2 reactivity of cerebral vessels can be con-
veniently assessed at the bedside by measuring the
CBF response to a decrease in PaCO2 produced by
hyperventilation or to an increase in PaCO2 from
hypoventilating or adding inspired CO2 (hypercapnia).
Typically, CO2 reactivity is measured as the change in
CBF as a fraction of the change in PaCO2:
Cerebrovascular CO2 ¼ ΔCBF %ð ÞΔPaCO2 mmHgð ÞAn important consideration is that changes in
PaCO2 may also affect ABP or ICP and therefore
changes in PaCO2 may alter CPP in addition to CVR.
In the ideal monitoring scenario, therefore, one would
monitor CBF (perhaps using TCD), ABP (using an
invasive arterial line or non-invasive photoplethysmo-
graphy device), PaCO2 (or end-tidal CO2 as a surro-
gate), and in some situations ICP.
Figure 2 demonstrates a CO2 reactivity test in a TBI
patient. In this case, the TCD-based flow velocity (Fv)
was measured during moderate hyperventilation aimed
to make the patient mildly hypocapnic. An important
consideration easily appreciated from Fig. 1 is that
during a CO2 reactivity test, any CO2 influence on ABP
or ICP may confound interpretation.
Cerebral autoregulation
While cerebrovascular CO2 reactivity assessment at-
tempts to gain insight into vascular function from the
response of cerebral vessels to changes in PaCO2, cere-
bral autoregulation assessment attempts to gain insight
into vascular function from the response of cerebral ves-
sels to changes in ABP (or in some cases CPP). In some
cases, where ABP or CPP is highly variable, the cerebral
Fig. 2 CO2 reactivity after TBI. CO2 reactivity is a measure indicating how well vascular responses in the brain are preserved. Mild hyperventilation
(PaCO2 challenge from 35 to 31.5 mmHg) is applied temporarily (1 h) in the patient after TBI. Right CBF velocity (FVR) in the middle cerebral
artery decreased from 120 to 100 cm/s. CO2 reactivity is calculated as ΔCBF velocity (%)/Δ PaCO2 and in this case reactivity is ~ 5 %/mmHg—very
good. However, at the same time ICP decreased from 32 to 27 mmHg and blood pressure (ABP) increased from 120 to 125 mmHg. Therefore,
CPP increased from 88 to 98 mmHg. The formula for cerebrovascular CO2 reactivity does not take into account the possible interaction between
chemoregulation and autoregulation. ABP arterial blood pressure, ICP intracranial pressure
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CBF averaged in groups of ABP or CPP (see Fig. 3). Such
dramatic swings in ABP or CPP are not always observed,
however, and therefore a typical assessment of cerebral
autoregulation involves inducing an ABP stimulus and
measuring the response of CBF. In clinical scenarios,
CBF is measured before and after a vasopressor is used
to augment ABP to give a point estimate of cerebral
autoregulation.
An alternative approach is to monitor continuously
the CBF response to natural slow variations in ABP [39].
Such an approach has some important caveats: the
natural ABP variations may not be strong enough to
challenge CBF, and changes in CBF could be caused by
factors other than ABP. However, the monitoring poses
no risk to the patients and has the distinct advantage
that it can assess long-term trends in cerebral autoregu-
lation within a patient.
The simplest methods of monitoring cerebral autoreg-
ulation assess how the slow changes of ABP occurring in
time compare with the slow changes in CBF (for review,
see [32]). An example of this is the mean flow index
(Mx), which measures the correlation between 30 con-
secutive 10-s averages of TCD mean CBF velocity and
CPP [40]. Methods using the frequency spectrum of the
signals are also available. By assuming that the cerebral
circulation acts as a high-pass filter (high-frequency
fluctuations in ABP pass through to Fv unimpededwhilst lower frequencies are dampened), transfer function
methods assess cerebral autoregulation using the phase
(shift in degrees required to align slow waves of ABP and
CBF velocity), gain (dampening factor), and coherence
(degree of association between ABP and Fv) [41]. NIRS
can also be used for assessment of cerebral autoregulation
in the time and frequency domain and is easier to apply in
many situations (less operator dependency compared with
TCD). NIRS-based autoregulation indices assess the rela-
tionship between CPP (or ABP) and NIRS-based cerebral
oxygenation.
The transient hyperaemic response test is an alterna-
tive form of cerebral autoregulation testing which in-
volves assessing the increase in TCD blood flow velocity
after release of a short (5–10 s) compression of the com-
mon carotid artery [42]. The degree of increase in blood
flow velocity in the seconds following release is thought
to be a reflection of the extent of cerebral vasodilation
in response to the reduced CPP during occlusion. An ex-
ample of a transient hyperaemic response test is shown
in Fig. 4.
In some cases, cerebral autoregulation can be esti-
mated using ICP as a surrogate for cerebral blood
volume. In this method, similarly to Mx, 30 consecutive
10-s averages of ABP are correlated with ICP to yield
the pressure reactivity index (PRx) [40]. A positive
correlation indicates passive transmission of ABP waves
to cerebral blood volume and hence ICP, while a negative
Fig. 3 Long-term invasive CBF and CPP monitoring. Example of the ‘Lassen curve’ depicting the relationship between CPP and CBF. It is derived
from a long-term plot of thermal-dilution CBF and CPP monitored in a patient after severe brain injury. The curve shows lower (LLA) and upper
(ULA) limits of autoregulation, outside which CBF is pressure passive. Notably, within the autoregulation range, CBF is not ideally stable but shows
an increase in CBF around the LLA, which is commonly observed in patients under mild hyperventilation (in this case PaCO2 was on average
32 mmHg). CBF cerebral blood flow, CPP cerebral perfusion pressure, ICP intracranial pressure
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of the cerebrovasculature and intact vasoreactivity.
PRx has the advantage that it can be easily measured
continuously in any patient with a parenchymal ICP
monitor, an arterial pressure line, and the appropriate
analysis software.
From a critical care perspective, the assessment of
cerebral autoregulation can be more practical than mon-
itoring CO2 reactivity because we can utilise the natural
fluctuations of ABP and therefore monitor cerebral auto-
regulation continuously. From a practical point of view,
to monitor cerebral autoregulation requires a continuous
estimate of CBF (NIRS or TCD are ideal), ABP (from an
arterial line or photoplethysmography), and in some
cases ICP.
Given the heterogeneity of CBF monitoring tech-
niques and the versatility of signal processing tech-
niques, a multitude of ‘indices’ or metrics of cerebral
autoregulation have been proposed. Table 2 highlights
the rationale of such indices and gives an opinion as
to their usefulness.Neurovascular coupling
The increase in CBF accompanying cerebral cortical ac-
tivation represents a further way of assessing the reactiv-
ity of vessels. Neurovascular coupling can be assessed
with either TCD or NIRS to detect increases in CBF in
response to cognitive, emotional, sensory, and motor
tasks (for a recent review, see [18]). Although less stud-
ied than pressure or CO2 reactivity in the critical care
population, neurovascular coupling assessment has great
potential because it can be assessed non-invasively and
repeatedly, and it reflects a physiologically distinct as-
pect of CBF regulation compared with CO2 or pressure
reactivity.
Clinical applications of bedside assessment of CBF
regulation
Using the methodologies described, the cerebral circula-
tion can be assessed in the critically ill patient. In this
particular setting, techniques such as TCD, NIRS, ICP,
and ABP monitoring are desirable as they can provide a
continuous assessment of cerebral circulation without
Fig. 4 (See legend on next page.)
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Fig. 4 Cerebral perfusion monitoring in SAH. On day 3 after ictus (top 4 panels), this patient with SAH from an aneurysm of the middle cerebral
artery displays a normal middle cerebral artery Fv (~60 cm/s) and intact autoregulation (TOxa and Mxa ~0 (suffix ‘a’ indicates that ABP is used
instead of CPP)). On day 7 (bottom 4 panels) a marked increase in Fv (to 120 cm/s) can be seen, which is accompanied by an impairment in
autoregulation (TOxa and Mxa close to 0). The transient hyperaemic response test also failed to show an increase in Fv after the release of
occlusion, an indicator of impaired cerebral autoregulation. ABP arterial blood pressure, Fv flow velocity, Mxa mean flow index (with ABP), TOxa
total oxygenation reactivity index (with ABP)
Table 2 Summary of autoregulation indices
Autoregulation metric Input signals Calculation Interpretation Comment
Autoregulation index (ARI) ABP, Fv Compares the CBF response
to changes in ABP with those
predicted from a parametric
model with 10 different
‘strengths’ of autoregulation [110]
ARI = 0 absent
autoregulation, ARI = 9
perfect autoregulation
Moderately complex signal
processing required
Flow index (Mx, Sx, Dx) ABP (CPP), Fv Pearson correlation between
CPP and mean Fv (300-s
window of 10-s averages). Sx
and Dx calculated with systolic
and diastolic flow velocity,
respectively
Impaired autoregulation =
higher Mx, Dx, and Sx
Simplistic yet prognostically
relevant
Transfer function (phase,
gain, coherence)
ABP, Fv Derived from the transfer function
of fast Fourier transform of ABP
and Fv signals. Phase is the shift
required to align Fv and ABP
signals, gain the transmission
from ABP to Fv, and coherence
the statistical association between
ABP and Fv
Impaired autoregulation =
low phase, high gain, high
coherence
Moderately complex signal
processing. Some prognostic
relevance
TOx, COx, THx, HVx ABP (CPP), NIRS
oxygenation
Pearson correlation between 30
consecutive 10-s means of ABP
and tissue oxygenation (or total
haemoglobin for THx and HVx)
Impaired autoregulation =
higher TOx, COx, THx, HVx
Correlated with TCD methods
but allows for longer term
monitoring
TOIHRx HR, NIRS oxygenation Correlation between 30 consecutive
10-s means of HR and NIRS
oxygenation
?Higher TOIHRx = impaired
autoregulation
Used in preterm infants.
Further comparisons with
standard autoregulation
indices required
Transfer function (phase,
gain, coherence)
ABP, NIRS oxygenation Derived from the transfer function
of fast Fourier transform of ABP
and oxygenation signals. Phase is
the shift required to align
oxygenation and ABP signals,
gain the transmission from ABP to
NIRS oxygenation, and coherence
the statistical association between
ABP and NIRS oxygenation
Impaired autoregulation =
low phase, high gain, high
coherence
Moderately complex signal
processing
PRx ABP, ICP Correlation between 30 consecutive
10-s means of ABP and ICP
Higher PRx = impaired
autoregulation
Robust measure for long
monitoring periods. Simplistic
and prognostically relevant
PAx ABP, amplitude of ICP Correlation between 30 consecutive
10-s means of ABP and ICP
Higher PAx = impaired
autoregulation
Similar to PRx, may allow
better estimate of pressure
reactivity when the
“pressure–volume”
compensatory curve is
flat, i.e. at low ICP
ORx CPP (ABP), PBTO2 Correlation between 30 consecutive
10-s means of ABP and PBTO2
High ORx = impaired
autoregulation
Further validation required
ABP arterial blood pressure, ARI autoregulatory index, CBF cerebral blood flow, COx cerebral oximetry index, CPP cerebral perfusion pressure, Dx diastolic flow
index, Fv flow velocity, HR heart rate, HVx haemoglobin volume reactivity index, ICP intracranial pressure, Mx mean flow index, ORx oxygen reactivity index,
PAx pressure amplitude index, PBTO2 pressure of brain tissue oxygen, PRx pressure reactivity index, Sx systolic flow index, NIRS near-infrared spectroscopy,
TCD transcranial Doppler, THx total haemoglobin reactivity index, TOIHRx total oxygenation heart rate index, TOx total oxygenation reactivity index
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Donnelly et al. Critical Care  (2016) 20:129 Page 10 of 17the need for transporting the patient. Unfortunately, val-
idated ‘normal’ reference ranges are seldom available for
the cerebral circulation and interpretation must there-
fore take into account relevant patient comorbidities and
the underlying physiologic milieu. In the following sec-
tion we summarise the role of the cerebral circulation in
TBI, SAH, stroke, sepsis, and prematurity.
Traumatic brain injury
The pathophysiology of TBI is classically split into
two phases, with the primary injury occurring at the
time of ictus and secondary injury occurring in the
following minutes, days, or even weeks. A cascade of
pathophysiologic events leads to altered cerebral and
systemic physiology that adds insult to injury; de-
rangements in glucose metabolism, thermoregulation,
respiration, and cerebral blood circulation all contrib-
ute to neuronal injury [43].
The characterisation of the cerebral circulation after
severe TBI is not straightforward partly because the dis-
ease entity itself is heterogeneous. Despite this diversity,
it is clear that maintaining close attention to cerebral
perfusion is essential in all patients. The cerebral circula-
tion is universally compromised after severe TBI; CBF,
CO2 reactivity, and cerebral pressure autoregulation can
all be impaired at various stages after TBI (Table 3). Low
CBF, high CBF [44–46], and impaired autoregulation
[47, 48] have all been associated with worse outcome (an
example of temporal variations in CBF regulation in a
TBI patient is shown in Fig. 5). However, while impaired
CO2 reactivity has been shown to be related to un-
favourable outcome in some studies [49, 50], this is not
universal. Carmona Suazo et al. [51] used parenchymal
brain tissue oxygen monitors to assess CBF in 90 TBI
patients and found that, while all patients seemed toTable 3 Cerebral haemodynamics in critical illness
Critical illness Effect of disease on cerebral haemodynamics
Flow Cerebral
autoregulation
CO2 reactivity
TBI Decreased [45, 46, 111]
then increased [46, 112]
Decreased [44, 113] Decreased [44
SAH Decreased (vasospasm)
[14, 55]
Decreased [54, 56] Decreased [5
Stroke Decreased [66, 67, 118] Decreased [70, 71] Decreased [6
Sepsis Unchanged [78, 81],
or decreased [5]
Unchanged [82],
decreased [78, 79],
or increased [83, 84]
Unchanged [
or decreased
Preterm infants Decreased [87, 89, 119] Unchanged [93] or
decreased [87, 88]
Decreased [8
CBF cerebral blood flow, CO2 carbon dioxide, SAH, subarachnoid haemorrhage; TBI,have a low CO2 reactivity on day 1, this gradually im-
proved over the first 5 days of monitoring. Interestingly,
CO2 reactivity on day 5 was higher in those with an
unfavourable outcome. Unfortunately, a low sample size
(n = 10 by day 5 of monitoring) and the potential for
confounding changes in CPP make the generalisability of
this surprising result uncertain.
Given that CBF seems to show a distinct time evolu-
tion after TBI [46, 52], defining an optimal CBF is clearly
problematic because it is likely to vary with the patients’
individual physiologic milieu, as well as the temporal
evolution of disease. Furthermore, continuous measure-
ments of CBF, although possible, are seldom feasible
(Table 1) and therefore ICU therapies dictate not CBF
per se but a target range of CPP. In this regard, individu-
ally optimising CPP to a continuously calculated meas-
ure of vascular reactivity such as PRx seems promising.
The CPP dependence of PRx can be used to assess at
which CPP the autoregulation is most efficient (i.e. the
CPP at which the PRx is most negative). This is potentially
important because CPP is a variable (unlike CBF or indices
of autoregulation) that can be titrated precisely at the bed-
side. Importantly, the difference between CPP and the opti-
mal CPP has been shown to be related to outcome [53].
Figure 6 demonstrates long-term continuous monitor-
ing of cerebral autoregulation using PRx in a TBI
patient. In this case, ICP was initially above 20 mmHg
and then subsided. The CPP varied between 60 and
100 mmHg, and when this CPP was plotted against PRx
a U-shaped, parabolic curve is observed with a mini-
mum at ~90 mmHg.
Subarachnoid haemorrhage
Spontaneous SAH most commonly results from rupture
of an intracranial aneurysm. Following SAH, severeDoes the cerebral haemodynamic parameter relate to
prognosis?
Flow Cerebral
autoregulation
CO2 reactivity
, 49, 114, 115] Yes: decreased
[44–46, 111] and
increased [44, 112]
CBF related to poor
outcome
Yes [44, 47] Most studies find
yes [44, 49], while
some find no [51]
5] Yes [62] Yes [60, 62, 116] Yes [117]
8, 69] Yes [66, 67] Yes [71] Yes [69]
82]
[77]
Unknown Unknown Unknown
8, 90] Yes [119] Yes [88, 95, 120] Yes [88, 90]
traumatic brain injury
Fig. 5 Continuous cerebral autoregulation monitoring during refractory intracranial hypertension. Continuous monitoring of cerebral autoregulation
using PRx in a patient after severe TBI, who died after 6 days because of refractory intracranial hypertension. During the first 3 days ICP was stable,
around 20 mmHg. However, PRx showed good autoregulation only during the first day (PRx <0.3). Later PRx was consistently above 0.5 even if ICP,
CPP, and brain tissue oxygenation (PbtiO2) were satisfactory. After day 4, PRx was persistently elevated to >0.7. On day 6, ICP increased abruptly to
70 mmHg, CPP fell to 20 mmHg, and oxygen tension fell below 5 mmHg. The patient died in a scenario of brain-stem herniation. The only parameter
which deteriorated early in this case was the index of cerebral autoregulation PRx. ABP arterial blood pressure, CPP cerebral perfusion pressure, ICP
intracranial pressure, PRx pressure reactivity index
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These are frequently related to large vessel spasm, but
may also be a sequelae of CBF dysregulation and a host
of other pathological processes, such as cortical spread-
ing depolarisations, acute inflammation, and loss ofFig. 6 Long-term monitoring of PRx in a patient after TBI. ICP was first elev
over 7 days of monitoring. PRx had parabolic distribution along the record
parabola indicates ‘optimal CPP’ from the whole 7-day period (90 mmHg in
guidelines—which illustrates well that CPP-oriented management must be
Moreover, such a fitting of an ‘optimal curve’ may be repeated in time, bas
tracing of ‘optimal CPP’ and targeting current CPP at its current optimal va
perfusion pressure, ICP intracranial pressure, PRx pressure reactivity indexblood–brain barrier—all of which have been implicated
in patient prognosis.
Early studies of experimental SAH in baboons revealed
impaired CBF, CO2 reactivity, and cerebral autoregula-
tion [54, 55]. However, like TBI, the clinical course ofated to 20 mmHg and then decreased, showing some fluctuations
ed range of CPP (from 60 to 100 mmHg). The minimum of this
this case—as compared with above 65–70 mmHg, advised by
individualised; it is not true that one shoe size is good for everybody).
ed on data from the past 4 h. This enables prospective detection and
lue, which may change in a course of intensive care. CPP cerebral
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Approximately 60 % of SAH cases develop vasospasm
on TCD, which may be accompanied by impaired CBF
and cerebral autoregulation [14, 56], and 15–30 %
develop delayed ischaemic deficits [57–59]. While the
relationship between vasospasm, delayed cerebral ischae-
mia, and outcome can be capricious, various aspects of
cerebral haemodynamics can be useful in predicting the
future clinical course: early impaired CO2 reactivity pre-
dicts vasospasm, and impaired cerebral autoregulation
predicts delayed ischaemic deficits and poor clinical out-
come [60, 61].
While CBF is typically within normal limits early after
ictus, it is possible to see impaired cerebral autoregula-
tion within the first 3–5 days after SAH [58, 60, 62].
Furthermore, Jaeger et al. [60] demonstrated that auto-
regulation can recover following the initial deterioration,
a response that indicates a good prognosis. Figure 4
demonstrates the time course of CBF regulation changes
in a patient after SAH.
Management strategies hinge on the early identifica-
tion of delayed cerebral ischaemia, followed by the insti-
tution of hypertension to maintain CBF. Currently,
nimodipine remains the only medication approved for
prevention of delayed cerebral ischaemia. In this respect,
optimisation of ABP according to cerebral autoregula-
tion may be a promising avenue of research [63].
Ischaemic stroke
Ischaemic stroke is characterised by luminal obstruction
by a blood clot. Thus, a region of the brain has abnor-
mally high resistance and decreased flow (Fig. 1). In
these patients, utmost importance is placed on prompt
dissolution of the clot either by thrombolysis or intravas-
cular clot removal [64]. Around the central core of
infarct is a zone of tissue with depleted, but not absent,
blood flow—the ischaemic penumbra. Prompt dissol-
ution of the clot can salvage this at-risk tissue.
Unlike TBI, or SAH, a predisposition for ischaemic
stroke can be determined by examination of cerebrovas-
cular regulation; those patients with impaired CO2 re-
activity are more likely to develop an ischaemic stroke
[65]. However, like TBI and SAH, ischaemic stroke is a
state where careful consideration of cerebrovascular
regulation in the acute phase is imperative (Table 3).
In the acute phase of ischaemic stroke, those patients
with the lowest global CBF tend to have worse prognosis
[66], as do those with a greater proportion of penumbral
to ischaemic tissue [67]. CO2 reactivity is depressed
compared with healthy controls [68, 69] and those with
lower CO2 reactivity have worse outcome [69]. Cerebral
autoregulation also appears to be impaired initially,
followed by further impairment over the ensuing several
days before again improving (reviewed in [70]). In 45ischaemic stroke patients, cerebral autoregulation im-
pairment was related to both the size of infarct and
functional outcome [71].
Ongoing controversy exists regarding how best to sup-
port the cerebral circulation after efforts to break down
the intramural obstruction. While the prevention of
hypotension after ischaemic stroke seems logical, know-
ledge of cerebral autoregulation has potential to help
guide the management of blood pressure. Studies of
continuous vascular reactivity are limited after ischaemic
stroke because these patients are often managed outside
the critical care environment without the insertion of in-
vasive ABP or cerebral perfusion monitors that allow for
continuous estimation of cerebral autoregulation. In this
regard, non-invasive perfusion assessment with NIRS and
ABP with finger photoplethysmography are promising.
Common to large ischaemic stroke, TBI, and SAH is
the occurrence of spreading cortical depolarisations.
These waves of near-complete depolarisation propagate
slowly through the cortex (over a time scale of about
1 min) and are followed by several minutes of markedly
depressed electrical activity [72, 73]. Their occurrence in
an injured brain may decrease CBF, resulting in areas of
ischaemia, and seem to lead to worse outcomes [74].
Whether they are a cause or a consequence (or both) of
altered cerebrovascular regulation needs further investi-
gation with simultaneous CBF circulation and electro-
cortical monitoring.
Sepsis
The host response to infection—sepsis—is charac-
terised by dysfunction of multiple organ systems, in-
cluding the brain. This host response can have
implications for CBF: CPP is often low, pyrexia can
alter CBF, and inflammatory mediators can alter vas-
cular resistance [75, 76]. Compared with the afore-
mentioned diseases, the cerebral circulation in sepsis
is less completely characterised.
Some studies have found impaired CO2 reactivity [77],
impaired autoregulation [78–80], and decreased CBF [5]
during sepsis, whilst other studies have found no signifi-
cant changes in CO2 reactivity, cerebral autoregulation,
or CBF [81, 82]. Interestingly, two groups have even
found that, in the early phases of experimental sepsis in
healthy volunteers, dynamic cerebral autoregulation is
actually enhanced [83, 84]. Pfister et al. [78] found that
autoregulation was impaired in those with sepsis and de-
lirium, but not in those with sepsis only. These seem-
ingly conflicting findings may be partially explained by
the heterogeneity of the sepsis process itself. Some septic
patients develop a hyperdynamic circulation with in-
creased cardiac output and decreased ABP, while others
have both decreased cardiac output and ABP. Moreover,
the physiological changes in the cerebral circulation
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comparisons between different studies difficult.
Nevertheless, brain dysfunction is one of the earliest
forms of organ dysfunction in sepsis and sepsis-induced
delirium occurs in up to 70 % of patients [76]. Charac-
terising the involvement of the cerebral circulation in
the pathogenesis of sepsis-induced delirium will prob-
ably require detailed haemodynamic studies with large
numbers of patients.
Preterm infants
Premature infants do not have fully functioning cerebral
vessels or cardiovascular systems and therefore vital
organ perfusion is vulnerable. Using NIRS and umbilical
artery ABP, continuous measures of cerebral autoregula-
tion can be obtained.
Animal studies indicate that cerebral autoregulation
starts to develop from around halfway through the ges-
tational period [85]. Furthermore, even when static auto-
regulation is developed, the preterm newborn probably
sits close to the lower limit of autoregulation [86]. Early
human investigations using Xe CT and NIRS indicated
that CBF, CO2 reactivity, and cerebral autoregulation
may be impaired in preterm infants [87–91] (Table 3).
Further, more recent human data using TCD indicated
that cerebral autoregulation is more impaired if the baby
is more premature [92]. Still other studies have indicated
that perhaps the premature brain is able to adapt to sus-
tained [93] but not dynamic [94] changes in ABP; that
is, ‘static’ autoregulation is intact, while ‘dynamic’ auto-
regulation may be impaired [91].
Analogous to TBI, determination of an optimal
ABP has been attempted in these preterm infants
with the finding that those who did not survive had
an ABP below their calculated optimal, whereas
those who developed periventricular haemorrhage
had an ABP above their optimal [95]. An important
consideration when interpreting studies on cerebral
haemodynamics in infants is that, in addition to the
influences of ABP and CO2 on CBF, arterial oxygen
saturation can be highly variable, and can have pro-
found influence on premature babies’ cerebral circu-
lation [96].
Future directions
With the increasing availability of bedside physiology
monitors and sophisticated online analysis software,
large-scale integrated interrogations of CBF regulation
are now possible. One important research theme is
developing robust prediction tools based on cerebral
physiologic monitoring for critically ill patients.
Accurate prognosis is of obvious importance for
patients, families, and clinicians alike, but current
methodologies have some limitations. For example,prognostic tools in TBI use clinical, laboratory, and
radiographic features on admission to predict patient
outcome [97]. However, some of the input variables
are open to interpretation (e.g. the grading of a CT
scan), and prognosis should ideally be updated based
on clinical and physiological developments. In this
sense, prognostic tools that update risk estimates
based on online monitoring of CBF regulation could
facilitate clinical decision-making.
In addition to predicting outcome, incorporating
knowledge of CBF regulation into management proto-
cols seems promising. Hopeful examples in TBI include
strategies that incorporate knowledge of cerebrovascular
reactivity into either ICP [98] or CPP [53] management.
Although still requiring further development and pro-
spective assessment, similar techniques could conceiv-
ably be applied to any condition where ABP or CBF
regulation is impaired.
Extending cerebral haemodynamic monitoring con-
cepts to other critical care pathologies is important.
For example, in cardiopulmonary bypass patients,
NIRS-based autoregulation has been shown to be a
significant predictor of outcome, and furthermore,
as in TBI, an autoregulation-based optimal ABP
seems to be prognostically important [99, 100]. An
example of autoregulation-based optimal ABP dur-
ing cardiopulmonary bypass is shown in Fig. 7. Car-
diac arrest, acute shunt blockage, acute liver failure,
pre-eclampsia, and malignant hypertension are all
conditions that could perturb the cerebral circula-
tion, and further investigation may reveal diagnostic,
prognostic, or therapeutic insight.
Understanding the factors that modify CBF and
vascular reactivity is also an important evolving area
of research. Although a large part of the variation in
cerebral autoregulation is accounted for by the level
of ABP (or CPP) itself, other systemic and local
factors may also be important. Preliminary investiga-
tions indicate that common occurrences in the crit-
ical care unit such as hyperglycaemia, altered renal
clearance, erythrocyte transfusion, or rewarming after
hypothermia are all associated with altered cerebral
pressure reactivity, underscoring the need for an in-
tegrative approach to neuromonitoring [101–104].
Finally, investigating and integrating additional aspects
of CBF regulation into prognostic and therapeutic
approaches is imperative. In particular, the compu-
terised assessment of neurovascular coupling [18]
and autonomic function (e.g. with baroreceptor sen-
sitivity or heart rate variability) are non-invasive,
provide unique information on the regulation of
CBF, and can be coupled with conventional measures
of CBF regulation such as cerebral autoregulation
and cerebrovascular CO2 reactivity.
Fig. 7 Monitoring of cerebral autoregulation during cardiopulmonary bypass surgery (re-analysis of raw data recording reported by Brady et al.
[100]). TCD-derived autoregulation index Mxa fluctuates seemingly in a chaotic manner during surgery (period of laminar flow is denoted by
near-zero pulse amplitude of the Fv waveform). However, its distribution along recorded blood pressure values resembles a parabolic curve—the
same as seen in TBI patients—with its minimum indicating hypothetical ‘optimal’ blood pressure (in this case 96 mmHg). Adapted with permission
of Prof. Charles Hogue and co-workers (John Hopkins Medical University) [100]. ABP arterial blood pressure, Fv flow velocity, Mxa mean flow index
(with ABP)
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To date, there is no randomised trial showing that moni-
toring the cerebral circulation improves care of neuro-
logical patients. The link between autoregulation status
and possible treatment is not firmly established, but
great hope is linked to the idea of treating patients with
an ‘optimal CPP’ (TBI or SAH) or ‘optimal ABP’ regime
(cardiac surgery, preterm infants, or conceivably sepsis).
However, these methodologies still await prospective
clinical studies.
With such a research focus on characterising
brain function in health, it is a sad fact that in
most cases our ability to monitor brain function
and the cerebral circulation in the critically ill
patient is rudimentary. Recent Neurocritical Care
Society guidelines attempt to correct this situation
[105]. With the maxim ‘time is brain’, a renewed
focus on high-fidelity cerebrovascular monitoring is
required—irreversible cerebral ischaemia can occur
in a matter of minutes.
Progress in the neurocritical care of vascular
diseases will probably also depend on moving away
from broad assumptions or ‘one size fits all’ physio-
logical targets; each patient brings a different
physiology which should be catered for. Using con-
tinuous markers of vascular function has the poten-
tial to optimise therapy to the individual patient’s
need. With the sophistication of signal processingand bioinformatic tools increasing exponentially, the
challenge lies in successful integration of cerebral
circulation monitoring paradigms at the bedside.
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